ArticleNanomaterials (Basel, Switzerland)2022
Switchable Terahertz Absorber from Single Broadband to Dual Broadband Based on Graphene and Vanadium Dioxide.
Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Design of a five peak tunnable metasurface for terahertz biological detection with vanadium dioxide.Scientific reports · 2025Article
- Actively Tunable "Single Peak/Broadband" Absorbent, Highly Sensitive Terahertz Smart Device Based on VOMicromachines · 2024Article
- Switchable and Tunable Terahertz Metamaterial Based on Vanadium Dioxide and Photosensitive Silicon.Nanomaterials (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
A multifunctional switchable terahertz (THz) absorber based on graphene and vanadium dioxide (VO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.